IRIS
SFRAMELI, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.660
NA - Nord America 1.592
AS - Asia 473
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 1
Totale 3.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.577
IE - Irlanda 523
CN - Cina 352
SE - Svezia 298
PL - Polonia 276
IT - Italia 198
DE - Germania 180
GB - Regno Unito 64
FI - Finlandia 54
SG - Singapore 50
IN - India 47
FR - Francia 29
VN - Vietnam 15
BE - Belgio 14
MX - Messico 14
EU - Europa 7
CZ - Repubblica Ceca 6
NL - Olanda 4
UA - Ucraina 3
BA - Bosnia-Erzegovina 2
ES - Italia 2
HK - Hong Kong 2
PH - Filippine 2
PT - Portogallo 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
A1 - Anonimo 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
HR - Croazia 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
NO - Norvegia 1
Totale 3.734
Salva come PNG Salva come JPEG
Città #
Dublin 522
Chandler 425
Warsaw 276
Nyköping 198
Beijing 165
Ashburn 129
Princeton 105
Ann Arbor 75
Medford 73
Jacksonville 71
Cambridge 57
Des Moines 46
Messina 43
Pune 43
Bremen 38
Lancaster 35
Boardman 34
Dearborn 30
Singapore 29
San Mateo 24
Shenyang 24
Jinan 21
Houston 20
Rome 20
Wilmington 20
Los Angeles 19
Tianjin 18
Nanjing 17
Nürnberg 17
Dong Ket 15
Hebei 15
Brussels 14
Ningbo 13
Hangzhou 10
New York 10
Zhengzhou 10
Guadalupe 9
Haikou 9
Munich 9
Taizhou 9
Falls Church 8
Palo Del Colle 7
Cagliari 6
Jiaxing 6
Brno 5
Changsha 5
Ciudad Benito Juárez 5
Guangzhou 5
Seattle 5
Woodbridge 5
Fort Worth 4
Fuzhou 4
Norwalk 4
Taiyuan 4
Caserta 3
Fairfield 3
Helsinki 3
Hemel Hempstead 3
Nanchang 3
Napoli 3
Northampton 3
Nynäshamn 3
Riposto 3
Segrate 3
Amsterdam 2
Bari 2
Batangas 2
Borgosatollo 2
Cazin 2
Clearwater 2
Frosinone 2
Galluccio 2
Glasgow 2
Hanover 2
Hong Kong 2
Kemerovo 2
Latina 2
London 2
Palermo 2
Paris 2
Patna 2
Porto 2
San Giuliano Milanese 2
San Vito Di Leguzzano 2
Shanghai 2
Augusta 1
Buffalo 1
Campagna 1
Catania 1
Cermes 1
Chattanooga 1
Cork 1
Dalian 1
Delhi 1
Enna 1
Fiano Romano 1
Hyderabad 1
Lago 1
Lanzhou 1
Lappeenranta 1
Totale 2.877
Salva come PNG Salva come JPEG
Nome #
Severe rhabdomyolysis in a patient with “Heat Stroke” 192
Clinical and molecular characterization of patients affected by congenital muscular dystrophies using next generation sequencing strategies 165
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 91
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 77
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 74
An observational study of functional abilities in infants, children, and adults with type 1 SMA 72
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 70
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 67
Effect of exercise on telomere length and telomere proteins expression in mdx mice 64
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 63
Pilot study of flavocoxid in ambulant DMD patients. 63
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 63
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 62
The 24-month PUL changes and steroids correlation. 61
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 61
Pilot study of flavocoxid in ambulant DMD patients. 60
Nusinersen versus sham control in later-onset spinal muscular atrophy 60
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 59
Pilot study of serial casting in muscular dystrophy patients. 59
Pilot study of serial casting of ankles in muscular dystrophy patients. 59
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 58
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 56
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 56
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 55
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 55
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 55
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 54
Autonomic nervous system involvement in spinal muscular atrophy. 54
Severe rhabdomyolysis in a patient with “Heat Stroke” 53
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 53
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 53
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 51
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 50
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 48
Development of an academic disease registry for spinal muscular atrophy 48
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 48
Pilot study of flavocoxid in ambulant DMD patients. 47
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 46
Old measures and new scores in spinal muscular atrophy patients 45
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 44
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with Duchenne muscular dystrophy: a skeckle tracking study. 44
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 44
Congenital myastenic syndromes due a novel GFPT1 mutation: a new Italian case 43
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies in the UK and differences with the Italian population 43
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study 43
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 42
The respiratory symptom check-list for patients with myotonic dystrophies: preliminary results. 42
Psychosocial impact of sport activity in neuromuscular disorders 42
study of flavocoxid in ambulant DMD patients. 41
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 41
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies: Analysis of the UK diagnostic service 2001-2013. 41
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 41
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 39
Stato dell'arte sulle terapie della Distrofia muscolare di Duchenne. 37
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 35
“I have got something positive out of this situation”: Psychological benefits of caregiving in relatives of young people with muscular dystrophy 34
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 34
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 33
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 31
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 31
Neuropsychiatric comorbidities in Duchenne Muscular Dystrophy. 31
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys 31
Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function 31
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 30
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 30
null 27
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 27
Clinical Variability in Spinal Muscular Atrophy Type III 27
Pilot study of flavocoxid in ambulant DMD patients. 26
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life Inventory TM neuromuscular Module in the Italian population and correlation with other functional assessments. 22
null 22
Sleep disorders in spinal muscular atrophy 21
null 20
null 20
Pilot study of flavocoxid in ambulant DMD patients. 19
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 18
null 18
The genetic spectrum of a large cohort of putative CMD. 16
The families of children with muscular dystrophies: burden, social network and professional support. 15
null 15
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen 15
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired 14
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 14
Screening for early symptoms of respiratory involvement in myotonic dystrophy type 1 using the Respicheck questionnaire 13
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy 11
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure 11
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 8
null 6
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 3
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function 2
Totale 3.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.467
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020511 0 5 10 13 14 55 42 44 30 172 81 45
2020/2021481 29 30 112 25 126 18 39 18 18 36 9 21
2021/2022499 3 43 5 34 24 4 45 19 8 57 39 218
2022/20231.458 99 149 69 107 131 128 10 71 649 9 29 7
2023/2024380 17 69 18 53 25 98 33 12 0 6 5 44
2024/202568 39 29 0 0 0 0 0 0 0 0 0 0
Totale 3.915